Skip to main content

Notice for iptacopan (Novartis Pharmaceuticals Australia Pty Ltd)

Active ingredients
iptacopan
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Hard capsule
Indication
Treatment of patients with paroxysmal nocturnal haemoglobinuria (PNH)
Therapeutic area
Haematology

Help us improve the Therapeutic Goods Administration site